Valuation: OraSure Technologies, Inc.

Market Cap 288M 257M 238M 215M 403M 27.36B 410M 2.86B 1.13B 14.31B 1.08B 1.06B 45.31B P/E 2026 *
-6.89x
P/E 2027 * -6.73x
Enterprise Value 288M 257M 238M 215M 403M 27.36B 410M 2.86B 1.13B 14.31B 1.08B 1.06B 45.31B EV / Sales 2026 *
2.37x
EV / Sales 2027 * 2.2x
Free-Float
93.51%
Yield 2026 *
-
Yield 2027 * -
1 day+0.97%
1 week+13.32%
Current month+6.38%
1 month+6.11%
3 months+5.04%
6 months+39.00%
Current year+72.31%
1 week 3.74
Extreme 3.742
4.38
1 month 3.59
Extreme 3.59
4.38
Current year 2.33
Extreme 2.33
4.58
1 year 2.08
Extreme 2.08
4.58
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
11.45
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 04/06/2022
Director of Finance/CFO 54 08/08/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 59 01/06/2020
Director/Board Member 66 08/11/2021
Director/Board Member 52 04/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
29/9/26 Free

Director

4,797 0.0070%
6/9/26 Tax

Chairman

-5,116 0.0074%
3/6/26 Free

Director

46,106 0.0670%
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%+13.32%+40.88%-20.72% 288M
+1.14%+0.79%-17.32%+11.60% 181B
-0.33%+2.75%-19.82%+18.39% 117B
-0.65%+2.18%+1.20%+34.70% 116B
-3.42%+15.09%-44.16%+5.61% 89.94B
-0.30%-2.94%-0.81%+74.97% 62.97B
+1.19%+1.60%+8.46%+82.17% 55.43B
-1.27%+2.96%+5.68%-22.74% 53.49B
+1.75%+2.59%-11.02%+43.47% 44.92B
+0.03%+6.23%-5.17%-7.53% 33.87B
Average -0.10%+4.43%-4.21%+21.99% 75.59B
Weighted average by Cap. -0.21%+3.26%-12.22%+24.54%

Financials

2026 *2027 *
Net sales 121M 108M 100M 90.86M 170M 11.54B 173M 1.21B 478M 6.04B 455M 446M 19.11B 131M 117M 108M 97.8M 183M 12.42B 186M 1.3B 514M 6.5B 490M 480M 20.57B
Net income -42.55M -38.05M -35.2M -31.87M -59.65M -4.05B -60.63M -424M -168M -2.12B -160M -156M -6.7B -44.17M -39.49M -36.54M -33.08M -61.92M -4.2B -62.93M -440M -174M -2.2B -166M -162M -6.96B
Net Debt - -
Projected Income Statement - Annual - OraSure Technologies, Inc.
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
26/10/26 US$4.170 +0.97% 1,021,984
23/10/26 US$4.130 +8.68% 1,158,244
22/10/26 US$3.800 -1.55% 538,592
21/10/26 US$3.860 +3.07% 404,316
20/10/26 US$3.745 +1.77% 406,439
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - OraSure Technologies, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.170USD
Average target price
5.500USD
Spread / Average Target
+31.89%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OraSure Technologies, Inc.
  1. Stock Market
  2. Stocks
  3. OSUR Stock